Induction of mucosal and systemic immune response by oral immunization with H-pylori lysates encapsulated in poly(D,L-lactide-co-glycolide) microparticles

被引:50
作者
Kim, SY [1 ]
Doh, HJ [1 ]
Ahn, JS [1 ]
Ha, YJ [1 ]
Jang, MH [1 ]
Chung, SI [1 ]
Park, HJ [1 ]
机构
[1] MOGAM Biotechnol Res Inst, Dept Immunol, Vaccine Lab 2, Koosung Myon 449910, Kyonggi Do, South Korea
关键词
poly(D; L-lactide-co-glycolide); microparticles; H-pylori; oral immunization;
D O I
10.1016/S0264-410X(98)00241-2
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Helicobacter pylori is a major cause of chronic antral gastritis and peptic ulcer diseases. Several kinds of poly(D,L-lactide-co-glycolide) microparticles containing H. pylori whole-cell lysate (PLG-HP) were prepared by the solvent evaporation method using double emulsion. Physical properties, such as particle size, protein content, and morphology were investigated. All prepared microparticles showed a smooth surface morphology from 0.5-0.86 mu m in diameter and high degree of encapsulation efficiency from 62-75%. SDS-PAGE and immunoblotting of extracted antigen confirmed that the molecular weight and antigenicity of the antigen remained unaltered by the encapsulation procedure. Following the oral immunization of the microparticles to mice, antibody production was assayed in serum and gut washings by ELISA and antibody secreting cells were determined in intestinal lamina propria lymphocytes (LPL) by ELISPOT. Multiple oral immunizations induced significant H. pylori-specific intestinal IgA response as well as serum IgG response than those detected with soluble antigen (P < 0.001). The presence of antibody-secreting cell in intestinal lamina propria lymphocytes (LPL) was correlated with IgA level in gut washing fluids. After boosting at week-8, the antibody induction levels were highly increased irrespective of microparticles prepared with different PLG molecular weights. These data suggested that PLG-HP could stimulate the H. pylori-specific mucosal and systemic response in vivo and might be useful adjuvant in future H. pylori vaccine development. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:607 / 616
页数:10
相关论文
共 41 条
  • [1] BIODEGRADABLE MICROSPHERES AS CONTROLLED-RELEASE TETANUS TOXOID DELIVERY SYSTEMS
    ALONSO, MJ
    GUPTA, RK
    MIN, C
    SIBER, GR
    LANGER, R
    [J]. VACCINE, 1994, 12 (04) : 299 - 306
  • [2] BUNGNOLI M, 1993, EUR J GASTROEN HEPAT, V5, P683
  • [3] CHALLACOMBE SJ, 1992, IMMUNOLOGY, V76, P164
  • [4] CHALLACOMBE SJ, 1995, CLIN IMMUNOL IMMUNOP, P76
  • [5] Single dose, polymeric, microparticle based vaccines: The influence of formulation conditions on the magnitude and duration of the immune response to a protein antigen
    Coombes, AGA
    Lavelle, EC
    Jenkins, PG
    Davis, SS
    [J]. VACCINE, 1996, 14 (15) : 1429 - 1438
  • [6] ANTIBODY-PRODUCING CELLS IN PERIPHERAL-BLOOD AND SALIVARY-GLANDS AFTER ORAL CHOLERA VACCINATION OF HUMANS
    CZERKINSKY, C
    SVENNERHOLM, AM
    QUIDING, M
    JONSSON, R
    HOLMGREN, J
    [J]. INFECTION AND IMMUNITY, 1991, 59 (03) : 996 - 1001
  • [7] A SOLID-PHASE ENZYME-LINKED IMMUNOSPOT (ELISPOT) ASSAY FOR ENUMERATION OF SPECIFIC ANTIBODY-SECRETING CELLS
    CZERKINSKY, CC
    NILSSON, LA
    NYGREN, H
    OUCHTERLONY, O
    TARKOWSKI, A
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1983, 65 (1-2) : 109 - 121
  • [8] ORAL IMMUNIZATION AGAINST HELICOBACTER-PYLORI
    CZINN, SJ
    NEDRUD, JG
    [J]. INFECTION AND IMMUNITY, 1991, 59 (07) : 2359 - 2363
  • [9] PROTECTION OF GERM-FREE MICE FROM INFECTION BY HELICOBACTER-FELIS AFTER ACTIVE ORAL OR PASSIVE IGA IMMUNIZATION
    CZINN, SJ
    CAI, A
    NEDRUD, JG
    [J]. VACCINE, 1993, 11 (06) : 637 - 642
  • [10] Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of Hsai-Labile enterotoxin as a mucosal adjuvant
    DiTommaso, A
    Saletti, G
    Pizza, M
    Rappuoli, R
    Dougan, G
    Abrignani, S
    Douce, G
    DeMagistris, M
    [J]. INFECTION AND IMMUNITY, 1996, 64 (03) : 974 - 979